Search Results - "Jacobs, Johanna E.J."

Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapy by Jacobs, Johanna E J, Greason, Grace, Mangold, Kathryn E, Wildiers, Hans, Willems, Rik, Janssens, Stefan, Noseworthy, Peter, Lopez-Jimenez, Francisco, Voigt, Jens-Uwe, Friedman, Paul, Van Aelst, Lucas, Vandenberk, Bert, Attia, Zachi Itzhak, Herrmann, Joerg

“…Cardiotoxicity is a serious side effect of anthracycline treatment, most commonly manifesting as a reduction in left ventricular ejection fraction (EF). Early…”
Get full text

Predictability of cardiotoxicity: Experience of a Belgian cardio-oncology clinic by Jacobs, Johanna E.J., Guler, Ipek, Duchenne, Jürgen, Janssens, Stefan, Van Aelst, Lucas N.L.

“…BACKGROUNDNew oncological treatments improved survival but also increased awareness of cardiovascular side-effects during and after cancer therapy. METHODSWe…”
Get full text

Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade by Jacobs, Johanna E J, L'Hoyes, Wouter, Lauwens, Lieselotte, Yu, Yu-Ling, Brusselmans, Marius, Weltens, Caroline, Voigt, Jens-Uwe, Wildiers, Hans, Neven, Patrick, Herrmann, Joerg, Thijs, Lutgarde, Staessen, Jan A, Janssens, Stefan, Van Aelst, Lucas N L

“…Background Treatment for breast cancer (BC) frequently involves radiotherapy. Guidelines recommend screening for cardiac adverse events starting 10 years after…”
Get full text